Search details
1.
Human DDK rescues stalled forks and counteracts checkpoint inhibition at unfired origins to complete DNA replication.
Mol Cell
; 81(3): 426-441.e8, 2021 02 04.
Article
in English
| MEDLINE | ID: mdl-33545059
2.
Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML.
Cell
; 151(2): 344-55, 2012 Oct 12.
Article
in English
| MEDLINE | ID: mdl-23063124
3.
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study.
Blood
; 137(13): 1792-1803, 2021 04 01.
Article
in English
| MEDLINE | ID: mdl-33024987
4.
Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial.
Lancet Oncol
; 22(11): 1597-1608, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34672961
5.
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.
Lancet Oncol
; 19(2): 216-228, 2018 02.
Article
in English
| MEDLINE | ID: mdl-29339097
6.
Geminin inhibits a late step in the formation of human pre-replicative complexes.
J Biol Chem
; 289(44): 30810-30821, 2014 Oct 31.
Article
in English
| MEDLINE | ID: mdl-25231993
7.
A phase 1 study of IDH305 in patients with IDH1R132-mutant acute myeloid leukemia or myelodysplastic syndrome.
J Cancer Res Clin Oncol
; 149(3): 1145-1158, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-35353219
8.
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia.
Blood
; 116(2): 171-9, 2010 Jul 15.
Article
in English
| MEDLINE | ID: mdl-20400682
9.
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab.
Clin Cancer Res
; 28(10): 2030-2037, 2022 05 13.
Article
in English
| MEDLINE | ID: mdl-35247915
10.
CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insights.
Leuk Res
; 121: 106928, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35963025
11.
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.
Bioorg Med Chem Lett
; 21(15): 4528-32, 2011 Aug 01.
Article
in English
| MEDLINE | ID: mdl-21719286
12.
Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score matching analysis.
Cancer Med
; 10(18): 6336-6343, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34427990
13.
Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia.
J Clin Oncol
; 39(1): 57-65, 2021 01 01.
Article
in English
| MEDLINE | ID: mdl-33119479
14.
Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial.
Lancet Haematol
; 7(4): e309-e319, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-32145771
15.
Structure-activity relationships of 6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)pyrido[2,3-d]pyrimidin-7-ones: toward selective Abl inhibitors.
Bioorg Med Chem Lett
; 19(24): 6872-6, 2009 Dec 15.
Article
in English
| MEDLINE | ID: mdl-19889540
16.
Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia.
Leukemia
; 33(11): 2575-2584, 2019 11.
Article
in English
| MEDLINE | ID: mdl-30967620
17.
Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia.
Leukemia
; 33(2): 390-402, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30038380
18.
Kinase-dead ATR differs from ATR loss by limiting the dynamic exchange of ATR and RPA.
Nat Commun
; 9(1): 5351, 2018 12 17.
Article
in English
| MEDLINE | ID: mdl-30559436
19.
Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized study.
J Infect
; 77(3): 227-234, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29746955
20.
A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure.
Clin Cancer Res
; 24(15): 3519-3527, 2018 08 01.
Article
in English
| MEDLINE | ID: mdl-29716921